During the past decade, Samsung Medical Center Clinical Trial Pharmacy conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samsung Medical Center Clinical Trial Pharmacy" #1 collaborator was "EMD Serono" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Samsung Medical Center Clinical Trial Pharmacy" are "Ovarian Cancer" (3 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Low Back Pain" (1 trials), "Renal Cell Cancer" (1 trials) and "Urothelial Cancer" (1 trials). Many other conditions were trialed in "Samsung Medical Center Clinical Trial Pharmacy" in a lesser frequency.

Most popular intervention types in "Samsung Medical Center Clinical Trial Pharmacy" are "Drug" (5 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (3 trials), "Avelumab (MSB0010718C)" (1 trials), "Axitinib (AG-013736)" (1 trials), "Azacitidine" (1 trials) and "Bendamustine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Samsung Medical Center Clinical Trial Pharmacy" are 4 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Samsung Medical Center Clinical Trial Pharmacy". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Samsung Medical Center Clinical Trial Pharmacy, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Samsung Medical Center Clinical Trial Pharmacy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".